首页> 外国专利> artificial antigen-presenting cell, method for expanding tumor infiltrating lymphocytes, treating cancer with a population of tumor infiltrating lymphocytes and for assessing the power of tumor infiltrating lymphocytes, kit, tumor infiltrating lymphocyte population, and, combination

artificial antigen-presenting cell, method for expanding tumor infiltrating lymphocytes, treating cancer with a population of tumor infiltrating lymphocytes and for assessing the power of tumor infiltrating lymphocytes, kit, tumor infiltrating lymphocyte population, and, combination

机译:人工抗原呈递细胞,扩增肿瘤浸润淋巴细胞,用肿瘤浸润淋巴细胞群治疗癌症和评估肿瘤浸润淋巴细胞能力的方法,试剂盒,肿瘤浸润淋巴细胞群以及它们的组合

摘要

in some embodiments, compositions and methods related to isolated antigen presenting artificial cells (aapcs) are disclosed, including aapcs comprising a myeloid cell transduced with one or more viral vectors, such as a molm-14 or an em-3 myeloid cell, wherein the endogenously myeloid cell expresses hla-a / b / c, icos-1, and cd58, and wherein the one or more viral vectors comprise a cd86-encoding nucleic acid and a 4-1bbl and / or ox40l-encoding nucleic acid and transduce the myeloid cell to express cd86 and 4-1bbl and / or ox401 proteins. In some embodiments, methods of expanding tumor infiltrating lymphocytes (t115) with aapcs and methods of treating cancers using thyls after expansion with aapcs are also disclosed.
机译:在一些实施方案中,公开了与分离的呈递抗原的人工细胞(apapc)有关的组合物和方法,包括包含用一种或多种病毒载体例如molm-14或em-3髓样细胞转导的髓样细胞的apc,其中内源性髓样细胞表达hla-a / b / c,icos-1和cd58,其中一个或多个病毒载体包含cd86编码核酸和4-1bbl和/或ox40l编码核酸并转导髓样细胞表达cd86和4-1bbl和/或ox401蛋白。在一些实施方案中,还公开了用apcs扩增肿瘤浸润淋巴细胞(t115)的方法和在用apcs扩增后使用thyls治疗癌症的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号